€380.00
2.56%
Stuttgart, Fri, Aug 01 2025
ISIN
DE000A0JDBC7
Symbol
LIK

Limes Schlosskliniken Target price 2025 - Analyst rating & recommendation

Limes Schlosskliniken Classifications & Recommendation:

Buy
80%
Hold
20%

Limes Schlosskliniken Price Target

Target Price €641.00
Price €380.00
Potential
Number of Estimates 1
1 Analyst has issued a Limes Schlosskliniken price target 2026. The average Limes Schlosskliniken target price is €641.00. This is higher than the current stock price.
A rating was issued by 5 analysts: 4 Analysts recommend Limes Schlosskliniken to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Limes Schlosskliniken stock has an average upside potential 2026 of . Most analysts recommend the Limes Schlosskliniken stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2030

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million € 38.00 43.90
26.46% 15.52%
EBITDA Margin 20.21% 24.84%
29.79% 22.91%
Net Margin 8.95% 11.70%
35.98% 30.76%

2 Analysts have issued a sales forecast Limes Schlosskliniken 2024 . The average Limes Schlosskliniken sales estimate is

€43.9m
Unlock
. This is
2.09% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€45.6m 6.13%
Unlock
, the lowest is
€42.6m 0.94%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 €38.0m 26.46%
2024
€43.9m 15.52%
Unlock
2025
€56.8m 29.32%
Unlock
2026
€67.1m 18.13%
Unlock
2027
€77.8m 15.98%
Unlock

2 Analysts have issued an Limes Schlosskliniken EBITDA forecast 2024. The average Limes Schlosskliniken EBITDA estimate is

€10.9m
Unlock
. This is
31.24% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€11.3m 36.44%
Unlock
, the lowest is
€10.6m 27.34%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 €7.7m 11.21%
2024
€10.9m 42.01%
Unlock
2025
€14.1m 29.31%
Unlock
2026
€16.7m 18.13%
Unlock
2027
€19.6m 17.49%
Unlock
2028
€22.8m 16.45%
Unlock
2029
€25.6m 12.15%
Unlock
2030
€28.2m 10.17%
Unlock

EBITDA Margin

2023 20.21% 29.79%
2024
24.84% 22.91%
Unlock
2025
24.84% 0.00%
Unlock
2026
24.84% 0.00%
Unlock

2 Limes Schlosskliniken Analysts have issued a net profit forecast 2024. The average Limes Schlosskliniken net profit estimate is

€5.1m
Unlock
. This is
20.09% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€5.3m 24.77%
Unlock
, the lowest is
€5.0m 16.59%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 €3.4m 19.05%
2024
€5.1m 51.18%
Unlock
2025
€8.0m 55.06%
Unlock
2026
€9.6m 20.58%
Unlock

Net Margin

2023 8.95% 35.98%
2024
11.70% 30.76%
Unlock
2025
14.05% 20.09%
Unlock
2026
14.33% 1.99%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2030

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share 11.72 17.72
18.27% 51.19%
P/E 21.45
EV/Sales 2.75

2 Analysts have issued a Limes Schlosskliniken forecast for earnings per share. The average Limes Schlosskliniken EPS is

€17.72
Unlock
. This is
20.14% higher
Unlock
than earnings per share in the financial year 2023. The highest EPS forecast is
€18.42 24.88%
Unlock
, the lowest is
€17.19 16.54%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 €11.72 18.27%
2024
€17.72 51.19%
Unlock
2025
€27.49 55.14%
Unlock
2026
€33.14 20.55%
Unlock

P/E ratio

Current 25.76 1.06%
2024
21.45 16.74%
Unlock
2025
13.82 35.57%
Unlock
2026
11.47 17.00%
Unlock

Based on analysts' sales estimates for 2024, the Limes Schlosskliniken stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.81 7.66%
2024
2.75 2.04%
Unlock
2025
2.13 22.67%
Unlock
2026
1.80 15.35%
Unlock

P/S ratio

Current 2.79 7.71%
2024
2.73 2.05%
Unlock
2025
2.11 22.67%
Unlock
2026
1.79 15.35%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today